May 17, 2010 (Orlando, Florida) — Patients with Parkinson's disease dementia (PDD) given oral rivastigmine for 24 weeks showed improvement on all symptom domains of the Alzheimer's Disease Assessment ...
ADAS-Cog mean scores changed minimally over 1 year in patients with mild-to-moderate Alzheimer’s disease treated with open-label simufilam tablets. 47% of patients improved on ADAS-Cog over 1 year, ...
Analysis of first-in-class CNS-101 study validates that at-home endpoints showed greater separation with Alzheimer's pathology (pTau217) than the benchmark endpoint Alzheimer's Disease Assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results